Analyst Ratings for Eliem Therapeutics Inc. (ELYM)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/10/2023 | H.C. Wainwright | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
3.34 (4.18) |
25.15% | Details |
4/25/2022 | Guggenheim | Yatin Suneja | Downgrade | Neutral (Buy) |
N/A (N/A) |
6.51 (4.18) |
-35.79% | Details |